In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Seizure diagnosis digital health start-up Ceribell closes $35mm Series B round

Executive Summary

Ceribell Inc. (electroencephalography (EEG) technology for seizure diagnosis) closed a $35mm Series B round co-led by new backers Optimas Capital Partners Fund and the Rise Fund. Returning investors, healthcare companies UCB (biopharmaceuticals) and LivaNova (implantable cardiac surgery and neuromodulation devices), also participated.
Deal Industry
  • Digital Health
  • Medical Devices
  • Medical Devices
    • Diagnostic Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies